BioClinica, a Pennsylvania-based specialty clinical trials technology services provider, has announced the roll out of a new eClinical CRO Partner Alliance program, accelerating adoption of industry-leading eHealth solutions by CROs. The decision to redesign the CRO partner channel comes in response to growing demand for a premier eClinical technology platform that enables CROs and sponsors to conduct studies in an efficient and accelerated manner.
“We listened to our eClinical CRO customers, sponsors and the wider community to understand business pain-points, as well as the overall experience of working with technology product providers,” said Mukhtar Ahmed, BioClinica’s eClinical business segment president. “Based on feedback from senior clinical development, outsourcing and IT executives, it was evident a completely different partnering approach and philosophy was desired.
“Among their top priorities are CRO autonomy and product self-service capability, as well as access to a wealth of knowledge and best practices. They want this within a true partnership one with strategic business alignment, collaboration and accountability for service delivery and product quality.”
In addition to BioClinica’s data, regulatory, reporting and analytics technology, CRO partners can tap into product innovation found within the eHealth App xChange. The App xChange enables access to a growing list of consumer applications, such as electronic health records, patient diaries, adherence, safety utilities, questionnaires, eTMF, and other patient-centric apps in a secure and scalable way through BioClinica's regulatory compliant eHealth Cloud architecture.